Treatment or prevention of respiratory viral infections with alpha thymosin peptides

Details for Australian Patent Application No. 2004232847 (hide)

Owner SciClone Pharmaceuticals, Inc.

Inventors Rudolph, Alfred R.; Tuthill, Cynthia W.

Agent Wrays

Pub. Number AU-B-2004232847

PCT Pub. Number WO2004/094991

Priority 60/470,420 15.05.03 US; 60/464,645 23.04.03 US

Filing date 23 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 20 November 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/094991 Priority application(s): WO2004/094991

20 November 2008 Application Accepted

  Published as AU-B-2004232847

19 March 2009 Standard Patent Sealed

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232848-Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics

2004232835-Screen for pre-eclampsia